MiR-21 Promotes Glioma Invasion by Targeting MMP Regulators.
暂无分享,去创建一个
T. Wurdinger | P. Linsley | S. Kesari | Anna M. Krichevsky | G. Gabriely | C. Esau | Rosetta Inpharmatics | Christine Esau
[1] H. Allgayer,et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.
[2] Shuomin Zhu,et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis , 2008, Cell Research.
[3] David E Levy,et al. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. , 2008, Genes & development.
[4] A. Krogh,et al. Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells* , 2008, Journal of Biological Chemistry.
[5] T. van Dyke,et al. Differential Apaf-1 levels allow cytochrome c to induce apoptosis in brain tumors but not in normal neural tissues , 2007, Proceedings of the National Academy of Sciences.
[6] Gregory J. Hannon,et al. microRNAs join the p53 network — another piece in the tumour-suppression puzzle , 2007, Nature Reviews Cancer.
[7] R. Weinberg,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.
[8] Ralph Weissleder,et al. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. , 2007, Cancer research.
[9] David M. Thomas,et al. RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer , 2007, Cancer and Metastasis Reviews.
[10] Jörg Hackermüller,et al. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. , 2007, Blood.
[11] K. Ghoshal,et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.
[12] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[13] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[14] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[15] Shuomin Zhu,et al. MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)* , 2007, Journal of Biological Chemistry.
[16] Shuomin Zhu,et al. miR-21-mediated tumor growth , 2007, Oncogene.
[17] David P. Bartel,et al. Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .
[18] C. Liang,et al. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro , 2007, Nature Protocols.
[19] L. Lim,et al. Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression , 2007, Molecular and Cellular Biology.
[20] Chunhong Ma,et al. Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. , 2007, Oncology reports.
[21] George A. Calin,et al. A MicroRNA Signature of Hypoxia , 2006, Molecular and Cellular Biology.
[22] O. Kent,et al. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.
[23] S. Taboga,et al. Downregulation of the RECK‐tumor and metastasis suppressor gene in glioma invasiveness , 2006, Journal of cellular biochemistry.
[24] John G Doench,et al. Recapitulation of short RNA-directed translational gene silencing in vitro. , 2006, Molecular cell.
[25] S. Freier,et al. Improved targeting of miRNA with antisense oligonucleotides , 2006, Nucleic acids research.
[26] R. Khokha,et al. Individual Timp Deficiencies Differentially Impact Pro-MMP-2 Activation* , 2006, Journal of Biological Chemistry.
[27] Jayant P. Menon,et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.
[28] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[29] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[30] I. Holen,et al. Role of osteoprotegerin (OPG) in cancer. , 2006, Clinical science.
[31] C. Croce,et al. A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[32] David N Louis,et al. Molecular pathology of malignant gliomas. , 2006, Annual review of pathology.
[33] Stijn van Dongen,et al. miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..
[34] P. Span,et al. Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. , 2005, European journal of cancer.
[35] W. Vandertop,et al. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma. , 2005, Cancer research.
[36] K. Kosik,et al. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. , 2005, Cancer research.
[37] K. Hui,et al. A microarray study to characterize the molecular mechanism of TIMP-3-mediated tumor rejection. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[38] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[39] J. Castle,et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.
[40] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[41] Anton J. Enright,et al. Human MicroRNA Targets , 2004, PLoS biology.
[42] R. Giegerich,et al. Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.
[43] H. Wada,et al. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer. , 2004, European journal of cancer.
[44] A. Aguzzi,et al. IL-6 is required for glioma development in a mouse model , 2004, Oncogene.
[45] F. Mannello,et al. Tissue inhibitors of metalloproteinases and programmed cell death: Conundrums, controversies and potential implications , 2001, Apoptosis.
[46] O. Tachibana,et al. Frequent LOH at Chromosome 12q22‐23 and Apaf‐1 Inactivation in Glioblastoma , 2003, Brain pathology.
[47] K. Alitalo,et al. Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[48] B. Li,et al. Expression profiling reveals off-target gene regulation by RNAi , 2003, Nature Biotechnology.
[49] L. Claesson‐Welsh,et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 , 2003, Nature Medicine.
[50] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[51] Y. Okada,et al. The role of matrix metalloproteinases in glioma invasion. , 2003, Frontiers in bioscience : a journal and virtual library.
[52] David B. Alexander,et al. The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis , 2001, Cell.
[53] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[54] M. Weller,et al. Molecular determinants of glioma cell migration and invasion. , 2001, Journal of neurosurgery.
[55] Ralph Weissleder,et al. In vivo molecular target assessment of matrix metalloproteinase inhibition , 2001, Nature Medicine.
[56] S. B. Bratton,et al. Recruitment, activation and retention of caspases‐9 and ‐3 by Apaf‐1 apoptosome and associated XIAP complexes , 2001, The EMBO journal.
[57] N. Yamamoto,et al. Adenovirus-mediated transfer of caspase-8 in combination with superrepressor of NF-kappaB drastically induced apoptosis in gliomas. , 2000, Biochemical and biophysical research communications.
[58] A. Merlo,et al. Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines. , 1999, Brain pathology.
[59] A. Baker,et al. ©1999 Cancer Research Campaign Article no. bjoc.1998.0217 Inhibition of invasion and induction of apoptotic cell , 2022 .
[60] P. Rothberg,et al. Oncogenes and cancer. , 1983, Cancer investigation.